Cargando…
Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
Monoclonal antibodies are the fastest growing therapeutic class in medicine today. They hold great promise for a myriad of indications, including cancer, allergy, autoimmune and infectious diseases. However, the wide accessibility of these therapeutics is hindered by manufacturing and purification c...
Autores principales: | Deal, Cailin E., Carfi, Andrea, Plante, Obadiah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910832/ https://www.ncbi.nlm.nih.gov/pubmed/33572679 http://dx.doi.org/10.3390/vaccines9020108 |
Ejemplares similares
-
Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
por: Zhao, Yuxiang, et al.
Publicado: (2023) -
mRNA as novel technology for passive immunotherapy
por: Schlake, Thomas, et al.
Publicado: (2018) -
An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretions
por: Deal, Cailin E., et al.
Publicado: (2023) -
Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1
por: Narayanan, Elisabeth, et al.
Publicado: (2022) -
mRNA therapeutics in cancer immunotherapy
por: Beck, Jan D., et al.
Publicado: (2021)